Cargando…

Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease

Evidence indicates that the metabolic inflammation induced by gut microbiota dysbiosis contributes to diabetic kidney disease. Prebiotic supplementations to prevent gut microbiota dysbiosis, inhibit inflammatory responses, and protect the renal function in DKD. Qing-Re-Xiao-Zheng formula (QRXZF) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yabin, Yang, Ruibing, Guo, Lan, Wang, Yaoxian, Liu, Wei Jing, Ai, Sinan, Woon, Ting Hui, Wang, Zheng, Zhai, Yuanyuan, Wang, Zhen, Peng, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481597/
https://www.ncbi.nlm.nih.gov/pubmed/34604258
http://dx.doi.org/10.3389/fmed.2021.719950
_version_ 1784576709265195008
author Gao, Yabin
Yang, Ruibing
Guo, Lan
Wang, Yaoxian
Liu, Wei Jing
Ai, Sinan
Woon, Ting Hui
Wang, Zheng
Zhai, Yuanyuan
Wang, Zhen
Peng, Liang
author_facet Gao, Yabin
Yang, Ruibing
Guo, Lan
Wang, Yaoxian
Liu, Wei Jing
Ai, Sinan
Woon, Ting Hui
Wang, Zheng
Zhai, Yuanyuan
Wang, Zhen
Peng, Liang
author_sort Gao, Yabin
collection PubMed
description Evidence indicates that the metabolic inflammation induced by gut microbiota dysbiosis contributes to diabetic kidney disease. Prebiotic supplementations to prevent gut microbiota dysbiosis, inhibit inflammatory responses, and protect the renal function in DKD. Qing-Re-Xiao-Zheng formula (QRXZF) is a Traditional Chinese Medicine (TCM) formula that has been used for DKD treatment in China. Recently, there are growing studies show that regulation of gut microbiota is a potential therapeutic strategy for DKD as it is able to reduce metabolic inflammation associated with DKD. However, it is unknown whether QRXZF is effective for DKD by regulating of gut microbiota. In this study, we investigated the reno-protective effect of QRXZF by exploring its potential mechanism between gut microbiota and downstream inflammatory pathways mediated by gut-derived lipopolysaccharide (LPS) in the kidney. High-fat diet (HFD) and streptozotocin injection-induced DKD mice model was established to assess the QRXZF effect in vivo. Mice treated with QRXZF for 8 weeks had significantly lower levels of urinary albumin, serum cholesterol and triglycerides. The renal injuries observed through histological analysis were attenuated as well. Also, mice in the QRXZF group had higher levels of Zonula occludens protein-1 (ZO-1) expression, lower levels of serum fluorescein-isothiocyanate (FITC)-dextran and less-damaged colonic mucosa as compared to the DKD group, implying the benefit role for the gut barrier integrity. QRXZF treatment also reversed gut dysbiosis and reduced levels of gut-derived LPS. Notably, the expression of toll-like receptor 4 (TLR4) and nuclear factor-κB (NF-κB), which are important inflammation pathways in DKD, were suppressed in the QRXZF groups. In conclusion, our results indicated that the reno-protective effects of QRXZF was probably associated with modulating gut microbiota and inhibiting inflammatory responses in the kidney.
format Online
Article
Text
id pubmed-8481597
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84815972021-10-01 Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease Gao, Yabin Yang, Ruibing Guo, Lan Wang, Yaoxian Liu, Wei Jing Ai, Sinan Woon, Ting Hui Wang, Zheng Zhai, Yuanyuan Wang, Zhen Peng, Liang Front Med (Lausanne) Medicine Evidence indicates that the metabolic inflammation induced by gut microbiota dysbiosis contributes to diabetic kidney disease. Prebiotic supplementations to prevent gut microbiota dysbiosis, inhibit inflammatory responses, and protect the renal function in DKD. Qing-Re-Xiao-Zheng formula (QRXZF) is a Traditional Chinese Medicine (TCM) formula that has been used for DKD treatment in China. Recently, there are growing studies show that regulation of gut microbiota is a potential therapeutic strategy for DKD as it is able to reduce metabolic inflammation associated with DKD. However, it is unknown whether QRXZF is effective for DKD by regulating of gut microbiota. In this study, we investigated the reno-protective effect of QRXZF by exploring its potential mechanism between gut microbiota and downstream inflammatory pathways mediated by gut-derived lipopolysaccharide (LPS) in the kidney. High-fat diet (HFD) and streptozotocin injection-induced DKD mice model was established to assess the QRXZF effect in vivo. Mice treated with QRXZF for 8 weeks had significantly lower levels of urinary albumin, serum cholesterol and triglycerides. The renal injuries observed through histological analysis were attenuated as well. Also, mice in the QRXZF group had higher levels of Zonula occludens protein-1 (ZO-1) expression, lower levels of serum fluorescein-isothiocyanate (FITC)-dextran and less-damaged colonic mucosa as compared to the DKD group, implying the benefit role for the gut barrier integrity. QRXZF treatment also reversed gut dysbiosis and reduced levels of gut-derived LPS. Notably, the expression of toll-like receptor 4 (TLR4) and nuclear factor-κB (NF-κB), which are important inflammation pathways in DKD, were suppressed in the QRXZF groups. In conclusion, our results indicated that the reno-protective effects of QRXZF was probably associated with modulating gut microbiota and inhibiting inflammatory responses in the kidney. Frontiers Media S.A. 2021-09-16 /pmc/articles/PMC8481597/ /pubmed/34604258 http://dx.doi.org/10.3389/fmed.2021.719950 Text en Copyright © 2021 Gao, Yang, Guo, Wang, Liu, Ai, Woon, Wang, Zhai, Wang and Peng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Gao, Yabin
Yang, Ruibing
Guo, Lan
Wang, Yaoxian
Liu, Wei Jing
Ai, Sinan
Woon, Ting Hui
Wang, Zheng
Zhai, Yuanyuan
Wang, Zhen
Peng, Liang
Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease
title Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease
title_full Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease
title_fullStr Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease
title_full_unstemmed Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease
title_short Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease
title_sort qing-re-xiao-zheng formula modulates gut microbiota and inhibits inflammation in mice with diabetic kidney disease
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481597/
https://www.ncbi.nlm.nih.gov/pubmed/34604258
http://dx.doi.org/10.3389/fmed.2021.719950
work_keys_str_mv AT gaoyabin qingrexiaozhengformulamodulatesgutmicrobiotaandinhibitsinflammationinmicewithdiabetickidneydisease
AT yangruibing qingrexiaozhengformulamodulatesgutmicrobiotaandinhibitsinflammationinmicewithdiabetickidneydisease
AT guolan qingrexiaozhengformulamodulatesgutmicrobiotaandinhibitsinflammationinmicewithdiabetickidneydisease
AT wangyaoxian qingrexiaozhengformulamodulatesgutmicrobiotaandinhibitsinflammationinmicewithdiabetickidneydisease
AT liuweijing qingrexiaozhengformulamodulatesgutmicrobiotaandinhibitsinflammationinmicewithdiabetickidneydisease
AT aisinan qingrexiaozhengformulamodulatesgutmicrobiotaandinhibitsinflammationinmicewithdiabetickidneydisease
AT woontinghui qingrexiaozhengformulamodulatesgutmicrobiotaandinhibitsinflammationinmicewithdiabetickidneydisease
AT wangzheng qingrexiaozhengformulamodulatesgutmicrobiotaandinhibitsinflammationinmicewithdiabetickidneydisease
AT zhaiyuanyuan qingrexiaozhengformulamodulatesgutmicrobiotaandinhibitsinflammationinmicewithdiabetickidneydisease
AT wangzhen qingrexiaozhengformulamodulatesgutmicrobiotaandinhibitsinflammationinmicewithdiabetickidneydisease
AT pengliang qingrexiaozhengformulamodulatesgutmicrobiotaandinhibitsinflammationinmicewithdiabetickidneydisease